Metoprolol- Toprol XL + Metoprolol- Lopressor
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Acute Myocardial Infarction
Conditions
Acute Myocardial Infarction
Trial Timeline
Feb 1, 2000 → Apr 1, 2002
NCT ID
NCT01523054About Metoprolol- Toprol XL + Metoprolol- Lopressor
Metoprolol- Toprol XL + Metoprolol- Lopressor is a phase 1 stage product being developed by AstraZeneca for Acute Myocardial Infarction. The current trial status is completed. This product is registered under clinical trial identifier NCT01523054. Target conditions include Acute Myocardial Infarction.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01523054 | Phase 1 | Completed |
Competing Products
20 competing products in Acute Myocardial Infarction